Viriathus


Also found in: Wikipedia.

Viriathus

 

Died 139 B.C.

Viriathus was a shepherd from the Lusitanian tribe. From 147 to 139 he headed the uprising of the Lusitanians against Rome, which lasted from 154 to 133. He was killed by his own retainers, who had been bribed by the Romans.

Mentioned in ?
References in periodicals archive ?
BNY Mellon will serve as Cardia Bioplastics' Principal American Liaison ("PAL") on OTCQX, responsible for providing guidance on OTCQX requirements, and Viriathus Capital LLC will act as the Company's exclusive OTCQX advisor.
ASX:ISN);(OTCQX:ISOAY), an emerging medical technology company developing innovative monitoring systems and software for the management of asthma, today announced that Viriathus Research LLC has issued an initial informational research report on the Company.
investment bank Viriathus Capital LLC will serve as iSonea's exclusive OTCQX Advisor and the Company has appointed Bank of New York Mellon ("BNY Mellon") as its depositary bank for the ADR program as well as its Principal American Liaison ("PAL") for OTCQX regulatory matters.
NEW YORK -- Viriathus Research LLC, an independent research firm, issued an Overview Report today on Benitec Limited (ASX: BLT), Benitec was formed to commercialize applications for RNA interference (RNAi) technology in treating chronic and life-threatening human conditions.
based trading platform offered by OTCQX and the advisory services offered by Viriathus Capital LLC," commented Avalon President, Don Bubar.
Viriathus Research has issued this report in connection with Viriathus Capital LLC Series' ("Viriathus Capital") OTCQX Advisory service for Shandong Luoxin Pharmacy Stock Co.
Viriathus Capital LLC ("Viriathus") acted as the Company's financial advisor and placement agent with respect to the offering of the Notes.
Viriathus Research is a quality-leading New York based independent equity research company that provides insightful, in-depth research coverage and informational reports to emerging growth companies worldwide and the institutions that invest in them.
NEW YORK -- Viriathus Research LLC, an independent research firm, issued an Overview Report today for Biosceptre International Limited, a public, unlisted Australian biotech company that is developing a range of patented antibodies with applications in the diagnosis and treatment of cancer.
Viriathus Capital LLC will be serving as Luoxin Pharma's exclusive OTCQX Advisor and The Bank of New York Mellon will serve as Luoxin Pharma's Principal American Liaison.
NEW YORK -- Viriathus Research LLC, an independent research firm, issued an Update Report today for Viralytics Limited (ASX: VLA) (OTC: VRACY), a biotechnology company that is developing therapies and drugs for the treatment of cancer in Australia.
VIRIATHUS RESEARCH ISSUES AN OVERVIEW REPORT FOR VIRTUAL MEDICAL CENTRE, LIMITED